Mereo BioPharma Group PLC (MREO)
2.805
+0.02
(+0.90%)
USD |
NASDAQ |
Apr 25, 16:00
2.86
+0.06
(+1.96%)
After-Hours: 20:00
Mereo BioPharma Group Price to Book Value: 7.785 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 7.715 |
| April 23, 2024 | 7.715 |
| April 22, 2024 | 7.743 |
| April 19, 2024 | 7.327 |
| April 18, 2024 | 7.355 |
| April 17, 2024 | 7.160 |
| April 16, 2024 | 7.466 |
| April 15, 2024 | 7.410 |
| April 12, 2024 | 7.549 |
| April 11, 2024 | 7.604 |
| April 10, 2024 | 8.160 |
| April 09, 2024 | 8.687 |
| April 08, 2024 | 8.798 |
| April 05, 2024 | 9.131 |
| April 04, 2024 | 9.048 |
| April 03, 2024 | 9.464 |
| April 02, 2024 | 9.381 |
| April 01, 2024 | 9.464 |
| March 28, 2024 | 9.159 |
| March 27, 2024 | 8.326 |
| March 26, 2024 | 8.187 |
| March 25, 2024 | 8.243 |
| March 22, 2024 | 8.270 |
| March 21, 2024 | 8.215 |
| March 20, 2024 | 8.604 |
| Date | Value |
|---|---|
| March 19, 2024 | 8.437 |
| March 18, 2024 | 8.576 |
| March 15, 2024 | 8.631 |
| March 14, 2024 | 8.715 |
| March 13, 2024 | 8.853 |
| March 12, 2024 | 9.714 |
| March 11, 2024 | 9.852 |
| March 08, 2024 | 9.936 |
| March 07, 2024 | 10.10 |
| March 06, 2024 | 10.35 |
| March 05, 2024 | 10.38 |
| March 04, 2024 | 10.71 |
| March 01, 2024 | 11.02 |
| February 29, 2024 | 10.55 |
| February 28, 2024 | 10.34 |
| February 27, 2024 | 10.73 |
| February 26, 2024 | 10.12 |
| February 23, 2024 | 10.20 |
| February 22, 2024 | 9.617 |
| February 21, 2024 | 9.811 |
| February 20, 2024 | 9.922 |
| February 16, 2024 | 10.28 |
| February 15, 2024 | 10.23 |
| February 14, 2024 | 10.06 |
| February 13, 2024 | 10.25 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2881
Minimum
Dec 24 2019
11.22
Maximum
Jan 29 2024
2.735
Average
2.102
Median
Jan 18 2023
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 6.653 |
| Biodexa Pharmaceuticals Plc | 0.5298 |
| NuCana PLC | 0.4264 |
| TC BioPharm (Holdings) PLC | 1.466 |
| Autolus Therapeutics PLC | 9.757 |
Price to Book Value Related Metrics
| PS Ratio | 37.00 |
| Price | 2.805 |
| Earnings Yield | -7.13% |
| Market Cap | 393.42M |